










































Human longevity is characterized at middle age by 
lower prevalence of myocardial infarction, hypertension 
and type 2 diabetes [1]. Also, middle aged offspring of 
long-lived families exhibit lower plasma levels of 
glucose and higher insulin sensitivity. This is in 
concordance with the findings from animal studies 
which revealed that the insulin/IGF1 signal transduction 
pathway is involved in lifespan (reviewed in [2]). In 
humans,  using  a  candidate  driven  approach,  we  and  
 
 










































others have shown that genetic variation in this pathway 
affects human longevity [3;4]. 
 
Type 2 diabetes (T2D) is characterized by an increased 
insulin resistance. In humans, insulin resistance as well as 
the prevalence of T2D increases with age. Long-lived 
subjects, such as centenarians and nonagenarian siblings, 
as well as their offspring, were found to exhibit a 
remarkably decreased prevalence of type 2 diabetes. 
Recently, offspring of longlived siblings were also found 
to have better glucose tolerance and higher insulin 
Polymorphisms associated with type 2 diabetes in familial longevity: 



























Abstract: Human longevity is in part genetically determined, and the insulin/IGF-1 signal transduction (IIS) pathway
has consistently been implicated. In humans, type 2 diabetes is a frequent disease that results from loss of glucose
homeostasis and for which new candidate polymorphisms now rapidly emerge from genome wide association studies. 
In the Leiden Longevity Study (n=2415), the offspring of long lived siblings (“offspring”) who are genetically enriched
for longevity were shown to have a more beneficial metabolic profile compared to their environmentally matched
partners (“controls”), including better glucose tolerance. We tested whether the "offspring" carry a lower burden of
diabetes risk alleles. Fifteen polymorphisms derived from genome wide association (GWA) scans in type 2 diabetes were
tested for association with parameters of glucose metabolism in offspring and controls, and burden of risk alleles was
compared between offspring and controls. 
Among all participants, a higher number of type 2 diabetes risk alleles associated with a higher prevalence of diabetes
(P=0.011) and higher serum concentration of glucose (P<0.016) but not insulin (P=0.450). None of the polymorphisms
differed in frequency between the offspring and controls (all P>0.05), nor did the mean total number of risk alleles
(P=0.977). The association between polymorphisms and glucose levels did not differ between controls and offspring
(Pinteraction=0.523). 
The better glucose tolerance of the "offspring" is not explained by a lower burden of type 2 diabetes risk alleles,
suggesting that specific mechanisms determining longevity exist. 
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assessment [5]. Since increased insulin sensitivity is 
associated with longevity, genetic determinants of T2D 
may be of interest for studies on longevity. In the last 
years, genome wide association (GWA) studies have 
identified several polymorphisms that associate with 
increased risk of T2D [6-9]. Replication studies [10-12] 
have shown the clinical relevance of a number of the 
identified loci. 
 
To investigate whether the better glucose tolerance 
phenotype in the offspring of long-lived individuals is 
due to lack of genetic variants associated with type 2 
diabetes, we analyzed 15 well established type 2 
diabetes variants in the Leiden Longevity Study [13] for 
their association with familial longevity. The objective 
of the present study was to investigate whether a lower 
burden of common genetic variants that have been 
associated with increased T2D in GWA studies can 
account for the beneficial glucose tolerance associated 




































The total study population consisted of 2415 
participants (1671 offspring; 744 controls). Baseline 
characteristics are shown in Table 2. The group of 
offspring was slightly older compared to their partners. 
The two groups were comparable with respect to 
measures of height, weight and body mass index, both 
crude and after adjustment for age and sex. Offspring 
from nonagenarian siblings had a lower prevalence of 
diabetes mellitus and hypertension as well as a slightly 
lower prevalence of myocardial infarction. In 
accordance with the lower prevalence of diabetes, 
offspring had lower glucose levels (P<0.001) and lower 
levels of insulin (P=0.006). After exclusion of all 
participants with diabetes, the association remained 
significant for glucose (P=0.001), but became non-






































SNP Gene/locus  Location  Risk  allele  References
 
Rs10497721  TMEFF2  2q32.3 A/C [21] 
Rs1801282  PPARG   3p25 C/G [12],  [22] 
Rs4402960  IGF2BP2   3q27.2 T/G [22],  [23] 
Rs10010131  WFS1   4q16 G/A [24],  [23] 
Rs7754840  CDKAL1   6p22.3 C/G [23],  [12] 
Rs13266634  SLC30A8   8q24.11 C/T [23],  [10] 
Rs564398  CDKN2A/2B  9q21 T/C [25],  [12] 
Rs10811661  CDKN2A/2B  9q21 T/C [10],  [22] 
Rs1111875  HHEX  10q23 C/T [26],  [23] 
Rs7903146  TCF7L2   10q25.2 T/C [27],  [10] 
Rs5219  KCNJ11   11p15.1 T/C [28],  [29] 
Rs1495377  TSPAN8  12q21.1 T2D  [9] 
Rs8050136  FTO   16q12.2 A/C [23],  [30] 
rs4430796  HNF1B  17q12 A/G [31],  [32] 
rs757210  HNF1B  17q12 T/C [31], 
 
Abbreviations: TMEFF2, transmembrane protein with EGF-like and 2 follistatin like domains 2; 
PPARG, peroxisome proliferator activated receptor γ; IGFBP2, IGF binding protein 2; WFS1, 
Wolfram Syndrome 1; CDKAL1, CDK5 reg. sub. Ass. protein 1; SLC30A8, solute carries family 30; 
CDKN2A/2B, cyclin-dependent kinase inhibitor 2A/2B; HHEX, Hematopoietically expressed 
Homeobox; TCF7L2, transcription factor 7 like 2; KCNJ11, Potassium channel inwardly rectifying 
submfamily J member 11; TSPAN8, tatraspanin8; FTO, fat mass and obesity associated; HNF1B, 
HNF1 homeobox B 
 
   































Association of T2D risk alleles with diabetes and 
glucose levels 
 
We observed an increasing prevalence of diabetes 
mellitus with an increasing number of T2D risk alleles 
(P = 0.011, Table 3). We also tested the association 
between numbers of risk alleles and serum parameters 
of glucose metabolism in the total group. With 
increasing numbers of risk alleles, we found an increase 
in glucose (P= 0.016) but not insulin (P=0.450). We 
found that the number of risk alleles was not associated 
with body mass index (BMI), and repeating the analyses 
with adjustment for BMI did not materially change the 
results (data not shown). After exclusion of participants 
with DM, statistical significance was lost for the 
association of number of alleles with levels of glucose 
(P = 0.089). In the oral glucose tolerance test increasing 
number of alleles associated with increasing area under 
the curve for glucose (P = 0.018). 
 
Allele frequencies in partners and offspring 
 
Next we tested the hypothesis that differences in allele 
































difference in prevalence of DM and differences in 
glucose and insulin levels between offspring and 
controls (Table 4). For none of the SNPs, the allele 
frequency was significantly different between offspring 
from familial nonagenarians compared to their partners. 
Likewise, no differences were found in the mean 
number of T2D risk alleles between the groups of 





To assess whether the offspring of nonagenarian sibling 
pairs were more protected against the influences of the 
risk alleles than the controls, we compared the increase 
in glucose dependent on the number of risk alleles in the 
offspring and controls. When analyzing offspring and 
controls separately, levels of glucose increased with an 
increasing number of number of risk alleles in offspring 
(P=0.016) and also in controls, albeit not significantly 
(P= 0.369). The increase in the control group did not 
reach statistical significance, possibly because of the 
smaller size of the group. The increase in glucose levels 
dependent on number of type 2 diabetes risk alleles was 
Table 2. Baseline characteristics of the study groups from the Leiden Longevity Study 
 
 Offspring  Controls  P-Value
  (n = 1671)  (n = 744)   
      
Demographics      
Age in years, mean (SD)  59.4 (6.5)  58.7 (7.5)  0.032 
Females, number (%)  900 (54%)  429 (58%)  0.083 
      
Antropometrics      
Height (cm), mean (95% CI)  172.9 (172.5-173.2)  172.9 (172.3-173.4)   0.951 
Weight (kg), mean (95% CI)  76.1 (75.4-76.8)  76.8 (75.8-77.8)  0.279 
Body mass index (kg/m2), mean (95% CI)  25.4 (25.2-25.6)  25.6 (25.3-25.9)  0.268 
      
Disease prevalence      
Diabetes Mellitus, number (%)  60 (4%)  47 (7%)  0.003 
Hypertension, number (%)  319 (23%)  179 (28%)  0.003 
Myocardial infarction, number (%)  33 (2%)  25 (4%)  0.040 
Stroke, number (%)  46 (3%)  18 (3%)  0.602 
      
Glucose metabolism      
Glucose (mmol/L) , mean (95% CI)  5.75 (5.70-5.81)  6.01 (5.92-6.09)  <0.001 
Insulin (mU/L), geometric mean (95% CI)  16.1 (15.5-16.8)  18.0 (16.9-19.1)  0.006 
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interaction = 0.538). A similar finding was found for 
the area under the curve in the oral glucose tolerance 



















































trend was seen, albeit not statistically significant (P = 
0.093 and P = 0.159 respectively) due to small 




















































  Stratum of number of risk alleles   
  5-13  14-15  16-23  P for trend 
 (n=731)  (n=647)  (n=712)   
        
Demographics       
Age in years, mean (SD)  59.2 (6.7)  59.1 (6.8)  59.6 (7.0)  0.541 
Females, number (%)  397 (54%)  359 (56%)  393 (55%)  0.981 
       
Antropometrics       
Height (m), mean (95% CI)  172.6 (172.1-173.1)  173.1 (172.6-173.7)  173.0 (172.4-173.5)  0.354 
Weight (kg), mean (95% CI)  76.0 (75.0-77.0)  76.5 (75.5-77.5)  76.3 (75.3-77.3)  0.446 
Body mass index (kg/m2), mean 
(95% CI) 
25.5 (25.2-25.8)  25.5 (25.2-25.8)  25.4 (25.1-25.7)  0.859 
       
Disease prevalence       
Diabetes Mellitus, number (%)  24 (3%)  28 (4%)  39 (6%)  0.011 
Hypertension, number (%)  140 (19%)  124 (21%)  153 (22%)  0.188 
Myocardial infarction, number (%)  21 (3%)  12 (2%)  19 (3%)  0.133 
Stroke, number (%)  20 (3%)  16 (3%)  19 (3%)  0.194 
       
Glucose metabolism       
Glucose (mmol/L) , mean (95% CI)  5.78 (5.70-5.87)  5.79 (5.69-5.88)  5.90 (5.82-5.99)  0.016 
Insulin (mU/L), geometric mean 
(95% CI) 

















































The main findings of the present study are twofold. 
First, we were able to replicate the association of SNPs 
discovered by GWA’s with T2D to associate with 
prevalence of diabetes and with glucose levels in the 
Leiden Longevity Study. Second, these polymorphisms 
did not differ in frequency or association with glucose 
levels between offspring of long-lived siblings and their 
partners. 
 
Despite our relatively small cohort, we were able to 
confirm in our population that SNPs associated with 
T2D in GWA’s also associate with prevalence of 
diabetes and levels of glucose in the Leiden Longevity 
Study. The effect sizes of associations with single SNPs 







































study population is relatively small to detect such small 
effect size we calculated the total number of risk alleles 
for each individual, to maximize power. This model 
assumes that there may be an additive effect of the 
SNPs.  We then stratified the total study population in 
tertiles of the numbers of risk alleles. Our findings are 
in line with a recent publication [14], in which it was 
described that an increasing number of risk alleles was 
associated with an increased prevalence of diabetes. 
 
We found no association of T2D risk alleles with 
familial longevity. Previously, in the same cohort we 
found the offspring to have better glucose tolerance than 
controls [5], which in clamp studies was concluded to 
result from differences in peripheral glucose disposure 




  Offspring Controls  P-Value
 
  (n = 1671)  (n = 744)   
Rs10497721             0.09  0.10  0.918 
Rs1801282             0.87  0.88  0.363 
Rs4402960 0.29  0.31  0.355 
Rs10010131 0.56  0.59  0.152 
Rs7754840 0.33  0.32  0.559 
Rs13266634 0.70  0.69  0.594 
Rs564398 0.57  0.57  0.970 
Rs10811661 0.83  0.82  0.473 
Rs1111875 0.60  0.59  0.280 
Rs7903146 0.27  0.27  0.816 
Rs5219 0.35  0.37  0.409 
Rs1495377 0.50  0.50  0.754 
Rs8050136 0.38  0.37  0.771 
Rs4430796 0.49  0.48  0.399 
Rs757210 0.39  0.38  0.357 
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difference in allele frequency between offspring and 
controls. One possible explanation lies in the function 
of the selected SNPs. Ten of the fifteen selected SNPs 
are associated with alterations in beta cell response [16]. 
Although the main driver of T2D is peripheral insulin 
resistance, compromised beta cell function is believed 
to be an important (genetic) factor in the pathogenesis 
of T2D. The onset of type 2 diabetes occurs when beta-
cell function cannot compensate for the high levels of 
insulin needed due to the peripheral insulin resistance. 
The fact that we find here that these SNPs do not 
account for the beneficial glucose handling in longevity 
is in line with our observation that beta cell function 
does not differ between partners and offspring in an oral 
glucose tolerance test [5]. The difference in glucose 
handling between offspring and controls might rather be 
determined by enhanced insulin sensitivity of the liver 
or peripheral tissues. Furthermore, in the same study 
population, we recently found no difference in disease 
risk allele frequencies between the long-lived parents of 
the offspring and younger controls [17]. This implicates 
that longevity that longevity is not compromised by risk 
alleles, but may rather be determined by protective 
alleles specific for longevity. Such mechanisms may for 
instance involve nutrient sensing pathways, such as 
mTOR, that affect insulin sensitivity [18]. Indeed, also 
in our study population, differential expression in 
mTOR signaling components was observed between 
offspring and controls in preliminary analyses [19]. 
More research is needed to elucidate the determinants of 
insulin sensitivity.  Taken together these data suggest 
that SNPs that associate with T2D identified by GWA 
studies and that associate with beta cell function are not 
major determinants of the beneficial glucose tolerance 




The Leiden Longevity Study.  Nonagenarian sibling 
pairs were included when aged older than 89 years for 
men and 91 years for women and having at least one 
sister or a brother fulfilling these age criteria, who was 
also willing to participate. Because proper controls are 
lacking at very high ages, the offspring of the 
nonagenarian siblings were asked to be included in the 
study as well. The partners thereof were included in the 
study to serve as a control group, representing the 
general population at an age comparable to the 
offspring. The total study population, excluding the 
nonagenarian siblings, consisted of 2415 participants 
(1671 offspring; 744 partners). The Medical Ethical 
Committee of the Leiden University Medical Centre 
approved the study and informed consent was obtained 
from all participants. 
 
Phenotyping. Blood samples were taken at baseline for 
extraction of DNA and the determination of non-fasted 
serum parameters. Glucose and insulin were available 
for 2337 and 2287 participants respectively. We 
collected additional information and biomaterials from 
the generation of offspring and partners, including self-
reported information on life style and bodily measures. 
Body height and weight were obtained from 1670 
participants. Body mass index was calculated from 
these data. Information on medical history was 
requested from the participants’ general practitioners. In 
a subgroup of 234 offspring and their partners we 
performed an oral glucose tolerance test. We calculated 
the area under the curve for each individual as a 
measure of glucose tolerance [5]. 
 
Genotyping 
Selection of Polymorphisms. We reviewed 266 GWAS 
that were published up to February 2009 
(http://www.genome.gov/26525384), 10 of which 
reported on type-2 diabetes. These 10 GWAS reported 
13 loci to be associated with type 2 diabetes (T2D) 
within at least two independent GWAS. To compile a 
set of disease risk alleles for each locus the most 
replicated SNP was selected and subsequently, in case 
of equal number of replications, the SNP with the 
lowest reported p-value. For two loci, one additional 
SNP was selected that was in low to moderate LD (r
2 < 
0.80) with the most replicated SNP. Thus 15 SNPs were 
selected for analysis, covering 13 loci (see Table 1).  
  
Genotyping.  These 15 SNPs were genotyped using 
Sequenom iPLEX. The average genotype call rate for 
these SNPs was 96.9% and the average concordance 
rate was 99.7% among 128 duplicated control samples. 
Complete genotyping of all 15 SNPs succeeded in 2090 
participants (87%). Because in complex human traits, 
single mutations are not expected to have large effects 
and are therefore hard to identify [20), we calculated for 
each individual the total number of T2D risk alleles. 
Demographic and antropometric data, disease 
prevalence and levels of glucose and insulin were 
compared between these groups. Allele frequencies 
were comparable to those described in the literature and 
all genotype distributions were in Hardy-Weinberg 
equilibrium. 
 
Statistical Analysis.  Continuous data were distributed 
normally except for levels of insulin, which was log 
transformed. Age, sex and disease prevalence 
frequencies are reported unadjusted. Means and 95%  
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insulin are reported adjusted for age and sex. 
Differences in disease prevalence between groups were 
assessed using logistic regression, adjusting for age and 
sex. Difference in antropometrics and levels of glucose 
and insulin were calculated using a linear regression 
model adjusting for age and sex. All p-values for 
differences between groups were adjusted for family 
relationships using robust standard errors, except for 
age and sex, which were calculated crude. Differences 
were considered significant when the p value was below 
0.05. All statistical analyses were performed with 
STATA (version 10.0, USA) and SPSS (version 16.0, 
USA), and in all analyses we made use of robust 
standard errors to account for familial relationships 
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